German Based Medical Tech Company Siemens Healthineers recently launched “Acuson Sequoia” a new imaging ultrasound system which enables imaging of different sized patients with unchanging clarity. The newly developed devices provide advanced high-powered architecture Deep Abdominal Transducer (DAX) and other improvements to elastography and contrast-enhanced ultrasound. To enable better diagnosis the device can produce penetration of up to 40cm to offer high-resolution imaging.
The inject is developed to achieve the natural outflow of aqueous humor by making two patent bypasses through the trabecular meshwork, glaucomatous eyes the main source of resistance resulting in multi-directional flow through Schlemm’s canal
Chief executive Dr. John Thompson, stated that the company also plans on targeting angel investors and a number of high-net-worth individuals in the new funding round. According to another report, AuriGen won a €2.5m funding boost from the EU-backed Horizon 2020 SME funding scheme amidst a lot of competition just last week.
Capsule-type micro-robots that can enclose cells and drugs for delivering to specified parts of the human body have been developed by an international team of researchers, led by the Director of DGIST-ETH Micro-robot Research Center, professor Hongsoo Choi. The lids of these micro-robots have been tailor-made to be opened and closed, unlike standard methods which have been positioned to install cells or drugs outside of micro-robots.
Sensome’s latest developed Clotild is focused on treating ischemic strokes. The company stated that even though there are numerous methods available for the treatment of the blocked brain arteries, it is difficult to ensure the right treatment or to control it, without identifying the composition of the clot first.
A research team from the University at Buffalo devised a technique named lung-on-a-chip technology using microlithography, where lab-grown lung tissue was placed upon a thin and flexible chip array. Fibrosis was artificially induced, where the lung cells were contracted and stiffened leading to scars in alveoli cells. This lung-on-a-chip technology could successfully test varied potential treatments against pulmonary fibrosis.
The heart cells are operated by Researchers from University of California San Diego School of Medicine in the US through the simple technique of shining a light and changing its intensity. The growth of the cells is facilitated through a material called graphene converting light into electricity and creating a relatively greater conducive environment than dished made from standard plastic or glass
Plymouth-based medical device maker Urotronic is ramping up clinical research on its Optilume drug-coated balloon to treat men with narrowed urethras, accelerating the data-gathering process for its novel device.
your submission has already been received.
Please enter a valid Email address！
The most relevant industry news & insight will be sent to you every two weeks.